Shuttle Pharmaceuticals Holdings SHPH
NASDAQ SHPH
$3.76 +0.00 (+0.00%)
At close: Aug 20, 2026 · 2:50 PM UTC

Shuttle Pharmaceuticals Holdings (SHPH) Other Accumulated Expenses (2021 - 2022)

Shuttle Pharmaceuticals Holdings (SHPH) posted quarterly Other Accumulated Expenses of $18904.0 for Q3 2022, up 3324.64% quarter-over-quarter from $552.0 in Q4 2021.

Shuttle Pharmaceuticals Holdings (SHPH) Other Accumulated Expenses (2021 - 2022) Analysis & Trends

Shuttle Pharmaceuticals Holdings' Other Accumulated Expenses history runs 2 years deep, the most recent figure standing at $18904.0 for Q3 2022.

  • In Q3 2022, Other Accumulated Expenses changed N/A year-over-year to $18904.0; the TTM figure through Sep 2022 stood at $18904.0 (changed N/A YoY), while the FY2021 annual figure was $552.0, changed N/A from the prior year.
  • Other Accumulated Expenses for Q3 2022 stood at $18904.0, up from $552.0 in the prior quarter.
  • The five-year high for Other Accumulated Expenses was $18904.0 in Q3 2022, with the low at $552.0 in Q4 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 43.86 Bn 42.90 Bn -
2 Teva Pharmaceutical Industries 43.19 Bn 39.54 Bn 2.15 Bn
3 Zoetis 31.46 Bn 29.79 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.57 Bn 22.77 Bn 5.10 Bn
5 United Therapeutics 22.15 Bn 19.49 Bn 683.80 Mn
6 Viatris 18.75 Bn 17.86 Bn 1.46 Bn
7 Neurocrine Biosciences 15.50 Bn 15.11 Bn 935.80 Mn
8 Elanco Animal Health 11.71 Bn 11.18 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.12 Bn 9.95 Bn -
10 Shuttle Pharmaceuticals Holdings 1.89 Mn 1.89 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2022 18,904.00
Dec 31, 2021 552.00